CAS 50-91-9 MFCD00006530-Floxuridine 5-氟-2-脱氧尿苷 TAO{mole}

Floxuridine 5-氟-2-脱氧尿苷

CAS 50-91-9 MFCD00006530

化学结构图

SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F

化学属性

Mol. Formula	C9H11FN2O5
Mol. Weight	246.19
Melting Point	148°C
Density	1.64
TSCA	No
Solubility	可溶
Appearance	白色结晶，无臭。易溶于水、甲醇，几乎不溶于氯仿和乙醚。mp 150-151℃。比旋度+37°、+48.6°(DMF)。紫外最大吸收波长268 nm (pH7.2)、 270 nm(pH14)。
Boiling Point	150 °C at 760 mmHg

别名和识别编码

Chemical Name	5-Fluoro-2′-deoxyuridine
CAS Number	50-91-9
Alfabeta Name	FLUORODEOXYURIDINE 52---'
MDL Number	MFCD00006530
Synonym	Floxuridine {LY} Floxuridine Fluorodeoxyuridine {} {LY} Floxuridine {} {} {LY} Floxuridine {} {} {} {LY} Floxuridine {} {} {} {} {LY} Floxuridine {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Floxuridine {} {} {} {} {} {} {} {} {} {} {} {} {} {}
EC Number	200-072-5
Beilstein Registry Number	2645818
PubChem Substance ID	5790
Merck Number	4112
Chemical Name Translation	5-氟-2-脱氧尿苷
Reaxys-RN	90221
Wiswesser Line Notation	T6NVMVJ EF A- ET5OTJ B1Q CQ
LabNetwork Molecule ID	LN00196507
InChI	InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
Canonical SMILES	OC[C@@H]1[C@@H](O)C[C@H](N2C(NC(C(F)=C2)=O)=O)O1

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

产品应用

抗肿瘤药。

安全信息

Warnings IRRITANT, TOXIC

Signal word

GHS Symbol

WGK Germany3

Safety Statements

S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时，立即求医（可能时出示标签）；
S20 When using do not eat or drink 使用时，不得进食，饮水；
S36/37 Wear suitable protective clothing and gloves 穿戴适当的防护服和手套；
S53 Avoid exposure - obtain special instructions before use 避免接触，使用前获得特别指示说明；
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护；
S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
S36 Wear suitable protective clothing 穿戴适当的防护服；
S22 Do not breathe dust 不要吸入粉尘；

Risk Statements

R68 Possible risk of irreversible effects 可能有不可挽回的作用的危险
R61 May cause harm to the unborn child 可能对未出生的婴儿导致伤害
R22 Harmful if swallowed 吞咽有害
R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性

Precautionary statements

P201 Obtain special instructions before use. 使用前获取专门指示。
P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前，切勿操作。
P203
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西，喝水或吸烟。
P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
P281 Use personal protective equipment as required. 使用所需的个人防护装备。
P301+P310
P301+P310+P330
P301+P316
P305+P351+P338
P308+P313
P318
P321 Specific treatment (see … on this label). 具体治疗（见本标签上的）。
P330 Rinse mouth. 漱口
P405 Store locked up. 上锁保管。
P501 Dispose of contents/container to..… 处理内容物/容器.....

Hazard statements

H301 Toxic if swallowed 吞食有毒
H341 Suspected of causing genetic defects 怀疑导致遗传性缺陷
H360 May damage fertility or the unborn child 可能对生育能力或未出生婴儿造成伤害

RTECSYU7525000

Personal Protective Equipment dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Packing GroupIII

UN Number 2811 UN 2811 6.1/PG 3

Hazard Codes Xn,T,Xi Xn

Storage condition 2-8°C {LY} 2-8°C 4℃保存 {} {LY} 2-8°C {} {} {LY} 2-8°C {} {} {} {LY} 2-8°C {} {} {} {} {LY} 2-8°C {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {}

Hazard Class6.1

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 215 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NCILB* Progress Report for Contract No. NIH-NCI-E-C-72-3252, Submitted to
   the National Cancer Institute by Litton Bionetics, Inc.  (Bethesda, MD)
   Volume(issue)/page/year: NCI-E-C-72-3252,1973

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Unreported
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 550 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   46,2703,1986

TYPE OF TEST            : TDLo - Lowe

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 147 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NCILB* Progress Report for Contract No. NIH-NCI-E-C-72-3252, Submitted to
   the National Cancer Institute by Litton Bionetics, Inc.  (Bethesda, MD)
   Volume(issue)/page/year: NCI-E-C-72-3252,1973

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 1600 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   CPCHAO Clinical Proceedings of the Children's Hospital of the District of
   Columbia.  (Washington, DC) V.1-27, 1971.  For publisher information, see
   CPNMAQ.  Volume(issue)/page/year: 18,307,1962

TYPE OF TEST            : Mutation test systems - not otherwise specified
TEST SYSTEM             : Human Cells - not otherwise specified
DOSE/DURATION           : 1 umol/L
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   42,3005,1982

TYPE OF TEST            : DNA inhibition
TEST SYSTEM             : Human Lymphocyte
DOSE/DURATION           : 10 umol/L
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   49,5829,1989

TYPE OF TEST            : Cytogenetic analysis
ROUTE OF EXPOSURE       : Oral
TEST SYSTEM             : Insect - Drosophila melanogaster
DOSE/DURATION           : 12500 ug/L
REFERENCE :
   CNJGA8 Canadian Journal of Genetics and Cytology.  (National Research
   Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6,
   Canada)  V.1-    1959-  Volume(issue)/page/year: 20,259,1978

TYPE OF TEST            : Mutation in micro

TYPE OF TEST            : Mutation test systems - not otherwise specified
ROUTE OF EXPOSURE       : Intraperitoneal
TEST SYSTEM             : Rodent - mouse
DOSE/DURATION           : 45 mg/kg
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 17,229,1978

TYPE OF TEST            : Mutation in microorgan

TYPE OF TEST            : Mutation test systems - not otherwise specified
TEST SYSTEM             : Human Mammary gland
DOSE/DURATION           : 100 umol/L
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   52,3418,1992

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10 mg/kg
SEX/DURATION            : female 16 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 29(2),5B,1984

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 25 mg/kg
SEX/DURATION            : female 12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 25,95,1982

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 25 mg/kg
SEX/DURATION            : female 10 day(s) after conception
TOXIC EFFECTS :
   Reproductiv

TYPE OF TEST            : TDLo - Low

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 60 mg/kg
SEX/DURATION            : female 9 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - Central Nervous System
   Reproductive - Specific Developmental Abnormalities - craniofacial

其他信息

Alfa Aesar:5-氟-2'-脱氧尿苷,98+% 5-Fluoro-2'-deoxyuridine, 98+%(50-91-9)
用途二:抗肿瘤药。
F:10-23
MOL 文件:50-91-9.mol
图谱信息:5-氟-2'-脱氧脲核苷(50-91-9)红外图谱(IR1) 5-氟-2'-脱氧脲核苷(50-91-9)红外图谱(IR2) 5-氟-2'-脱氧脲核苷(50-91-9)核磁图( 1 HNMR) 5-氟-2'-脱氧脲核苷(50-91-9)核磁图( 13 CNMR) 5-氟-2'-脱氧脲核苷(50-91-9)质谱(MS)
上游原料:5-氟脲嘧啶 --> 糖苷
5-氟-2'-脱氧脲核苷价格(试剂级):更新日期产品编号产品名称包装价格 2011/04/16 D2235 2'-脱氧-5-氟尿苷 2'-Deoxy-5-fluorouridine 500MG 2230元 2011/04/16 D2235 2'-脱氧-5-氟尿苷 2'-Deoxy-5-fluorouridine 100MG 800元 2010/06/21 227605000 5-氟-2'-脱氧脲核苷 (+)-5-Fluoro-2'-deoxyuridine 99+% 500 MG 7478元
5-氟-2'-脱氧脲核苷价格(试剂级):更新日期产品编号产品名称包装价格 2014/06/02 D2235 2'-脱氧-5-氟尿苷 2'-Deoxy-5-fluorouridine 500MG 2710元 2014/06/02 D2235 2'-脱氧-5-氟尿苷 2'-Deoxy-5-fluorouridine 100MG 968元 2010/06/21 227605000 5-氟-2'-脱氧脲核苷 (+)-5-Fluoro-2'-deoxyuridine 99+% 500 MG 7478元
Hazard Note:Toxic
比旋光度:35.9 ° (c=1, water)
毒害物质数据:50-91-9(Hazardous Substances Data)
EPA Substance Registry System:50-91-9(EPA Substance)
TCI Shanghai:5-氟-2'-脱氧尿苷 2'-Deoxy-5-fluorouridine,>;98.0%(T)(50-91-9)
方法一:甲基-2-去氧-D-呋喃核糖苷经对甲苯甲酰化、乙酸-盐酸水解使1位甲氧基被氯取代，再与1-乙酰氧汞-5-氟尿嘧啶缩合，生成物经水解去掉对甲苯甲酰基而得。
用途一:抗肿瘤药。适用于治疗肝癌、胃肠道癌、乳腺癌及头颈部癌。可有骨髓抑制。胃肠道反应和皮肤局部反应等副作用与氟尿嘧啶相似。亦有碱性磷酸酶、血清转氨酶、血清胆红质和乳酸脱氢酶等增高现象。